![Alexey Vinogradov](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alexey Vinogradov
Directeur/Membre du Conseil chez
XENETIC BIOSCIENCES, INC.
Fortune : 78 265 $ au 31/08/2026
Profil
Alexey Andreevich Vinogradov is Director at Pharmsynthez PJSC since 2023.
Director at Avelas Biosciences, Inc. since 2017.
Independent Non-Executive Director at Xenetic Biosciences, Inc. since 2019.
Director-Operations & Business Development at Cantreva LLC since 2017.
Formerly Independent Director at Argos Therapeutics, Inc. from 2014 to 2016.
Investment Manager at Bioprocess Capital Partners Ltd. in 2010.
Managing Partner at Pharmstandard Ventures.
General Manager at Togas Middle East LLC from 2015 to 2017.
Branch Manager at Togas Group LLC from 2012 to 2016.
Education includes a doctorate from Moscow State University Lomonosov.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2025 | 18 679 ( 0,8% ) | 78 265 $ | 31/08/2026 |
Postes actifs de Alexey Vinogradov
| Sociétés | Poste | Début |
|---|---|---|
| XENETIC BIOSCIENCES, INC. | Directeur/Membre du Conseil | 19/07/2019 |
| PHARMSYNTHEZ | Directeur/Membre du Conseil | 03/08/2023 |
Avelas Biosciences, Inc.
 Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Develops integrated suite of therapeutic and imaging agents for treatment of cancer | Directeur/Membre du Conseil | 14/03/2017 |
Cantreva LLC | Directeur des opérations | 01/09/2017 |
Anciens postes connus de Alexey Vinogradov
| Sociétés | Poste | Fin |
|---|---|---|
Togas Middle East LLC | Corporate Officer/Principal | 01/05/2017 |
Togas Group LLC | Corporate Officer/Principal | 01/11/2016 |
| ARGOS THERAPEUTICS, INC. | Directeur/Membre du Conseil | 10/06/2016 |
Bioprocess Capital Partners Ltd.
 Bioprocess Capital Partners Ltd. Investment ManagersFinance BCP invests in companies located in Russia. The firm targets companies operating in the fields of biotechnology, chemistry industry development and telecommunications. It provides financing for seed and early stage capital requirements. | Private Equity Investor | 31/12/2010 |
Pharmstandard Ventures
 Pharmstandard Ventures Investment ManagersFinance Pharmstd Ventures is an active manager which seeks investment opportunities in Russia and in the CIS states. The firm provides equity financing for sectors such as therapeutic and manufacturing industries. | Directeur Général | - |
Formation de Alexey Vinogradov
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
47
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes personalized immunotherapies for the treatment of cancer and infectious diseases | Health Technology |
Moscow State University Lomonosov
 Moscow State University Lomonosov Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmsynthez PJSC
 Pharmsynthez PJSC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Bioprocess Capital Partners Ltd.
Bioprocess Capital Partners Ltd. Investment ManagersFinance BCP invests in companies located in Russia. The firm targets companies operating in the fields of biotechnology, chemistry industry development and telecommunications. It provides financing for seed and early stage capital requirements. | Finance |
Avelas Biosciences, Inc.
Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Develops integrated suite of therapeutic and imaging agents for treatment of cancer | Health Services |
Pharmstandard Ventures
Pharmstandard Ventures Investment ManagersFinance Pharmstd Ventures is an active manager which seeks investment opportunities in Russia and in the CIS states. The firm provides equity financing for sectors such as therapeutic and manufacturing industries. | Finance |
Xenetic Biosciences, Inc.
 Xenetic Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic drugs, novel oncology therapeutics, and vaccinations | Health Technology |
Cantreva LLC | |
Togas Middle East LLC | |
Togas Group LLC |
